ENDRA Life Sciences Inc. - NDRA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 04, 2026 | Chief Financial Officer | A | A | 13,461.0 | 0.0 | 0.0 | 33,461.0 | View | |
| Mar 04, 2026 | Chief Executive Officer | A | A | 26,921.0 | 0.0 | 0.0 | 101,926.0 | View | |
| Jan 23, 2026 | — | A | A | 60,324.0 | 0.0 | 0.0 | 136,589.0 | View | |
| Jan 23, 2026 | — | A | A | 60,324.0 | 0.0 | 0.0 | 65,710.0 | View | |
| Jan 23, 2026 | Chief Financial Officer | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Jan 23, 2026 | — | A | A | 60,324.0 | 0.0 | 0.0 | 65,709.0 | View | |
| Jan 23, 2026 | Chief Executive Officer | A | A | 75,000.0 | 0.0 | 0.0 | 75,005.0 | View | |
| Oct 15, 2025 | — | A | A | 141,644.0 | 7.06 | 1,000,006.64 | 141,644.0 | View | |
| Oct 15, 2025 | — | A | A | 70,822.0 | 7.06 | 500,003.32 | 76,265.0 | View |